Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma

Authors:

Abstract
No abstract available
Funding Information
  • NCI (R01CA101795)
  • NIDA (R01DA030338)
  • NIH (U54CA210181)
  • Cancer Prevention and Research Institute of Texas (DP150099, RP150611, RP170537)
  • Department of Defense (DoD) (BC151081)
  • Golfer Against Cancer Foundation

This publication has 46 references indexed in Scilit: